Calcium channel blockers for primary and secondary Raynaud's phenomenon.

about

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

Item

http://www.wikidata.org/entity/Q47316559

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

@en

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

@nl

type

Item

label

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

@en

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

@nl

prefLabel

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

@en

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

@nl

P1476

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

@en

P2093

Elizabeth Tanjong Ghogomu

http://www.w3.org/2001/XMLSchema#string

Fadumo Rirash

http://www.w3.org/2001/XMLSchema#string

George A Wells

http://www.w3.org/2001/XMLSchema#string

Lara J Maxwell

http://www.w3.org/2001/XMLSchema#string

Paul C Tingey

http://www.w3.org/2001/XMLSchema#string

Sarah E Harding

http://www.w3.org/2001/XMLSchema#string

P2860

Drug interventions versus placebo for the treatment of Raynaud’s phenomenon: generic protocol

Measuring inconsistency in meta-analyses

Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.

A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon

Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon

The minimally important difference and patient acceptable symptom state for the Raynaud's condition score in patients with Raynaud's phenomenon in a large randomised controlled clinical trial

Clinical practice. Raynaud's Phenomenon.

Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.

Clinical and rheological effects of nifedipine in Raynaud's phenomenon

Prevalence of symptoms of Raynaud's phenomenon in general practice

P304

CD000467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1002/14651858.CD000467.PUB2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Janet Pope

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29237099

http://www.w3.org/2001/XMLSchema#string

P932

6486273

http://www.w3.org/2001/XMLSchema#string